Effect of propantheline bromide and pipenzolate bromide upon exocrine pancreatic secretion.
D002766:Cholecystokinin; D006801:Humans; D007273:Injections, Intramuscular; D010179:Pancreas / Q000187:drug effects*; D010182:Pancreatic Diseases / Q000175:diagnosis; D010189:Pancreatic Juice / Q000378:metabolism*; D010276:Parasympatholytics / Q000494:pharmacology*; D011413:Propantheline; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D012633:Secretin; D014966:Xanthenes / Q000494:pharmacology*
D010276:Parasympatholytics; D000644:Quaternary Ammonium Compounds; D014966:Xanthenes; D011413:Propantheline; D012633:Secretin; D002766:Cholecystokinin